Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPM8 | Q7Z2W7 | 3/20 | 0.64 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.64 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31026599 | 1.00 | TRPM8 (0.64) | TRPM8TRPA1EPHX1ALDH1A1LMNA | |
| SCHEMBL30903487 | 1.00 | TRPM8 (0.64) | TRPM8TRPA1EPHX1ALDH1A1LMNA | |
| SCHEMBL31591896 | 1.00 | TRPM8 (0.64) | TRPM8TRPA1EPHX1ALDH1A1LMNA | |
| SCHEMBL8631770 | 1.00 | TRPM8 (0.64) | TRPM8TRPA1EPHX1ALDH1A1LMNA | |
| SCHEMBL13619076 | 1.00 | TRPM8 (0.64) | TRPM8TRPA1EPHX1ALDH1A1LMNA | |
| SCHEMBL8632495 | 1.00 | TRPM8 (0.64) | TRPM8TRPA1EPHX1ALDH1A1LMNA | |
| SCHEMBL8630667 | 1.00 | TRPM8 (0.64) | TRPM8TRPA1EPHX1ALDH1A1LMNA | |
| SCHEMBL8634813 | 1.00 | TRPM8 (0.64) | TRPM8TRPA1EPHX1ALDH1A1LMNA | |
| SCHEMBL8630319 | 1.00 | TRPM8 (0.64) | TRPM8TRPA1EPHX1ALDH1A1LMNA | |
| SCHEMBL30903488 | 1.00 | TRPM8 (0.64) | TRPM8TRPA1EPHX1ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3137049-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Givaudan SA (CH) | 2017-03-08 | — | — | EP | claimed |
| WO-2015165582-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2015-11-05 | — | — | WO | claimed |
| WO-2008068059-A2 | URINE-ABSORBING COMPOSITION WITH FRAGRANCE RELEASE UPON USE | EVONIK DEGUSSA GMBH (DE) | 2008-06-12 | — | — | WO | claimed |
| EP-1888668-A1 | ALCOHOL ODOROUS SUBSTANCE-RELEASING POLYSILOXANE | Evonik Degussa GmbH (DE) | 2008-02-20 | — | — | EP | claimed |
| WO-2006131430-A1 | ALCOHOL ODOROUS SUBSTANCE-RELEASING POLYSILOXANE | EVONIK DEGUSSA GMBH (DE) | 2006-12-14 | — | — | WO | claimed |
| US-12617763-B2 | Hydroboration-oxidation process | FIRMENICH SA (CH) | 2026-05-05 | — | — | US | disclosed |
| EP-4114815-B1 | HYDROBORATION-OXIDATION PROCESS | FIRMENICH & CIE (CH) | 2024-03-13 | — | — | EP | disclosed |
| CN-111954665-B | Novel lactone compounds and novel ether compounds | 高砂香料工业株式会社 | 2023-08-15 | — | — | CN | disclosed |
| US-20230120264-A1 | HYDROBORATION-OXIDATION PROCESS | FIRMENICH SA (CH) | 2023-04-20 | — | — | US | disclosed |
| US-20230120264-A1 | HYDROBORATION-OXIDATION PROCESS | FIRMENICH SA (CH) | 2023-04-20 | — | — | US | disclosed |
| EP-4114815-A1 | HYDROBORATION-OXIDATION PROCESS | Firmenich SA (CH) | 2023-01-11 | — | — | EP | disclosed |
| CN-115135629-A | Hydroboration-oxidation process | 弗门尼舍有限公司 | 2022-09-30 | — | — | CN | disclosed |
| WO-2014072857-A1 | TRIGGERABLE COMPOSITIONS FOR TWO-STAGE, CONTROLLED RELEASE OF ACTIVE CHEMISTRY | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2014-05-15 | — | — | WO | disclosed |
| CN-102557880-B | Method for synthesizing p-menthane-3,9-diol | CHINA TOBACCO HUNAN IND CO LTD | 2014-04-16 | — | — | CN | disclosed |
| CN-102557880-B | Method for synthesizing p-menthane-3,9-diol | CHINA TOBACCO HUNAN IND CO LTD | 2014-04-16 | — | — | CN | disclosed |
| CN-102557880-A | Method for synthesizing p-menthane-3,9-diol | CHINA TOBACCO HUNAN IND CO LTD | 2012-07-11 | — | — | CN | disclosed |
| CN-102557880-A | Method for synthesizing p-menthane-3,9-diol | CHINA TOBACCO HUNAN IND CO LTD | 2012-07-11 | — | — | CN | disclosed |
| US-7332633-B2 | Process for the preparation of optically active cyclohexenones | FIRMENICH SA (CH) | 2008-02-19 | — | — | US | disclosed |
| US-5892133-A | CONTAINING A 3-SUBSTITUTED P-MENTHANE | TAKASAGO INTERNATIONAL CORPORATION (JP) | 1999-04-06 | — | — | US | disclosed |
| CN-1038670-C | Cyclohexanone derivative, cold sensitive agent and cold sensitive composition containing same and preparation of same and intermediate | HISAMITSU PHARMACEUTICAL CO (JP) | 1998-06-10 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230120264-A1 | HYDROBORATION-OXIDATION PROCESS | CYP11B2, HAO2, POR | TRPM8 2573/4885TRPA1 1292/4885EPHX1 320/4885 |
| US-12617763-B2 | Hydroboration-oxidation process | CFH, DOHH, AKR1B10 | TRPM8 1508/4885TRPA1 1553/4885EPHX1 242/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.